| Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 419 | 2021 |
| Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital A Vallano, G Cereza, C Pedròs, A Agustí, I Danés, C Aguilera, JM Arnau British journal of clinical pharmacology 60 (6), 653-658, 2005 | 288 | 2005 |
| Regulatory framework for advanced therapy medicinal products in Europe and United States C Iglesias-López, A Agustí, M Obach, A Vallano Frontiers in pharmacology 10, 471441, 2019 | 157 | 2019 |
| β-Adrenergic blocking agents in heart failure: Benefits of vasodilating and nonvasodilating agents according to patients' characteristics: A meta-analysis of clinical trials S Bonet, A Agustí, JM Arnau, X Vidal, E Diogene, E Galve, JR Laporte Archives of Internal Medicine 160 (5), 621-627, 2000 | 131 | 2000 |
| Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors A San-José, A Agustí, X Vidal, F Formiga, M Gómez-Hernández, J García, ... BMC geriatrics 15, 1-9, 2015 | 118 | 2015 |
| Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction: Towards an understanding of factors influencing clinical practice KL Woods, D Ketley, A Lowy, A Agusti, C Hagn, R Kala, NB Karatzas, ... European heart journal 19 (1), 74-79, 1998 | 112 | 1998 |
| An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain C Pedrós, A Vallano, G Cereza, G Mendoza-Aran, A Agustí, C Aguilera, ... Drug safety 32, 77-83, 2009 | 95 | 2009 |
| Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing A San-José, A Agustí, X Vidal, F Formiga, A López-Soto, ... European journal of internal medicine 25 (8), 710-716, 2014 | 77 | 2014 |
| Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer. V Plaza, A Crespo, J Giner, JL Merino, D Ramos-Barbón, EF Mateus, ... Journal of investigational allergology & clinical immunology 25 (6), 431-437, 2015 | 63 | 2015 |
| Policies to enhance the efficiency of prescribing in the Spanish Catalan Region: impact and future direction A Coma, C Zara, B Godman, A Agustí, E Diogène, B Wettermark, ... Expert review of pharmacoeconomics & outcomes research 9 (6), 569-581, 2009 | 61 | 2009 |
| Inappropriate prescribing in elderly people with diabetes admitted to hospital F Formiga, X Vidal, A Agusti, D Chivite, B Rosón, J Barbé, A López‐Soto, ... Diabetic Medicine 33 (5), 655-662, 2016 | 48 | 2016 |
| Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period M Martinez, A Agusti, JM Arnau, X Vidal, JR Laporte European journal of clinical pharmacology 54, 203-208, 1998 | 42 | 1998 |
| Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States C Iglesias-Lopez, M Obach, A Vallano, A Agustí Cytotherapy 23 (3), 261-274, 2021 | 41 | 2021 |
| Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos A Vallano Ferraz, A Agustí Escasany, C Pedrós Xolvi, JM Arnau de Bolós Gaceta Sanitaria 26, 277-283, 2012 | 41 | 2012 |
| Outcomes of off-label drug uses in hospitals: a multicentric prospective study I Danés, A Agustí, A Vallano, C Alerany, J Martínez, JA Bosch, A Ferrer, ... European journal of clinical pharmacology 70, 1385-1393, 2014 | 39 | 2014 |
| Tratamiento médico de la insuficiencia cardíaca basado en la evidencia AA Escasany, MD Dalmau, DR Cumplido, ED Fadini, JMA de Bolós, ... Revista Española de Cardiología 54 (6), 715-734, 2001 | 39 | 2001 |
| Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction: meta-analysis of randomised clinical trials A Agustí, S Bonet, JM Arnau, X Vidal, JR Laporte Drug safety 26, 895-908, 2003 | 38 | 2003 |
| Current landscape of clinical development and approval of advanced therapies C Iglesias-Lopez, A Agustí, A Vallano, M Obach Molecular Therapy-Methods & Clinical Development 23, 606-618, 2021 | 37 | 2021 |
| Reactogenicity and immunogenicity of BNT162b2 in subjects having received a first dose of ChAdOx1s: initial results of a randomised, adaptive, phase 2 trial (CombiVacS) AM Borobia, AJ Carcas, M Pérez Olmeda, L Castaño, M Jesús Bertrán, ... | 36 | 2021 |
| Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective KL Woods, D Ketley, A Agusti, C Hagn, R Kala, NB Karatzas, ... European heart journal 19 (9), 1348-1354, 1998 | 36 | 1998 |
